The National Institute of Mental Health has awarded a significant grant of $1.5 million to Jianyang Du, PhD, of the ...
Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...
Faster post-COVID-19 recovery is observed after infection with the Omicron vs earlier variants, regardless of vaccination status.
New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDAâ„¢ (pemivibart) against XEC Centers for Disease ...
SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). Phosphorothioate-linked guanosine 12mer inhibits ...
The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, began in late 2019 in Wuhan ... So far there have been several variants of the virus -- B.1.1.7, B.1.351, P.1, Delta, B.1.617.2 ...
A study in Ecuador reveals the rapid emergence of SARS-CoV-2 variants, highlighting the importance of strengthening genomic ...
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...